Knockdown of Myostatin Expression by RNAi Enhances Muscle Growth in Transgenic Sheep

Shengwei Hu, Wei Ni, Wujiafu Sai, Ha Zi, Jun Qiao, Pengyang Wang, Jinliang Sheng, Chuangfu ChenPLoS 2013 · DOI

Abstract

Myostatin (MSTN) is a negative regulator of skeletal muscle development. This study explored using RNA interference (RNAi) to generate transgenic sheep with a "double-muscle" phenotype. By combining shRNA-based knockdown with somatic cell nuclear transfer (SCNT), researchers produced three live transgenic lambs. Molecular analysis confirmed the integration and expression of the shRNA, leading to significant inhibition of MSTN protein. These transgenic sheep exhibited faster weight gain and larger myofiber diameters compared to controls, demonstrating a promising approach for enhancing livestock productivity.

Introduction

In livestock production, enhancing muscle growth is a primary goal. Myostatin (MSTN) acts as a natural "brake" on muscle development; its absence in certain cattle breeds results in extreme muscularity. However, traditional gene knockout in sheep is difficult due to the lack of stable embryonic stem cell lines. This study investigates whether RNA interference (RNAi)—which reduces rather than eliminates gene expression—can effectively promote muscle growth in sheep while avoiding the potential health complications associated with complete gene knockouts.

Methods and Vector Design

The researchers developed a multi-step bioengineering pipeline. First, they designed a plasmid vector containing a short hairpin RNA (shRNA) expression cassette specifically targeting sheep MSTN mRNA.

Schematic of the shRNA expression cassette used to target Myostatin.

Sheep fibroblast cells were transfected with this vector, and stable clones were selected. These engineered nuclei were then used in somatic cell nuclear transfer (SCNT) to create cloned embryos, which were transferred into recipient ewes. Out of 429 embryos, five lambs were born, with three (M17, M18, and M23) surviving for long-term study.

Molecular Validation and Key Results

The success of the genetic modification was verified through several molecular assays. PCR confirmed the integration of the transgene, while RNase protection assays (RPA) demonstrated that the shRNA was actively expressed in the muscle tissues of the transgenic lambs.

Molecular validation of transgenic sheep: (A, B) PCR confirmation of transgene integration; (C) RPA showing shRNA expression; (D) Western Blot showing reduced MSTN protein levels.

The most significant finding was the reduction of MSTN protein levels. In lamb M17, MSTN expression was inhibited by 61.12% compared to controls. This molecular knockdown translated into a clear physical phenotype:

  • Weight Gain: At three months, M17 weighed 25.42 kg, significantly higher than the control average of 21.22 kg. M17’s daily weight gain was 0.23 kg/day, compared to 0.18 kg/day for controls.
  • Muscle Histology: Histological analysis revealed that the mean myofiber diameter in M17 was 58 µm, compared to 47 µm in control sheep, indicating that muscle growth was driven primarily by hypertrophy (increased fiber size).

Discussion and Insights

The study revealed that knocking down MSTN triggers a regulatory cascade, upregulating myogenic factors like MyoD and Myogenin. Interestingly, phenotypic variability was observed; despite being derived from the same cell line, M17 showed much stronger suppression than M18. This suggests that the genomic location of the transgene insertion ("position effects") or epigenetic factors during the cloning process play a critical role in the final outcome.

Limitations and Future Outlook

While successful, the study notes several challenges. The cloning efficiency remains low (1.2%), and the small sample size limits broad statistical conclusions. Furthermore, the long-term health, meat quality, and fertility of these transgenic animals require further investigation. Future efforts may utilize more precise gene-editing tools like CRISPR/Cas9 to achieve similar results without the need for antibiotic resistance markers.

Summary updated

Abstract

Myostatin (MSTN) has been shown to be a negative regulator of skeletal muscle development and growth. MSTN dysfunction therefore offers a strategy for promoting animal growth performance in livestock production. In this study, we investigated the possibility of using RNAi-based technology to generate transgenic sheep with a double-muscle phenotype. A shRNA expression cassette targeting sheep MSTN was used to generate stable shRNA-expressing fibroblast clones. Transgenic sheep were further produced by somatic cell nuclear transfer (SCNT) technology. Five lambs developed to term and three live lambs were obtained. Integration of shRNA expression cassette in three live lambs was confirmed by PCR. RNase protection assay showed that the shRNAs targeting MSTN were expressed in muscle tissues of three transgenic sheep. MSTN expression was significantly inhibited in muscle tissues of transgenic sheep when compared with control sheep. Moreover, transgenic sheep showed a tendency to faster increase in body weight than control sheep. Histological analysis showed that myofiber diameter of transgenic sheep M17 were bigger than that of control sheep. Our findings demonstrate a promising approach to promoting muscle growth in livestock production.
BibTeX
@inproceedings{hu2013knockdown,
  author = {Shengwei Hu and Wei Ni and Wujiafu Sai and Ha Zi and Jun Qiao and Pengyang Wang and Jinliang Sheng and Chuangfu Chen},
  title = {{Knockdown of Myostatin Expression by RNAi Enhances Muscle Growth in Transgenic Sheep}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0058521},
}
Figure